OBJECTIVE: To compare the outcome of renal replacement treatment in patients with diabetes mellitus and in non-diabetic patients with end stage renal failure. DESIGN: Retrospective comparison of cases and matched controls. SETTING: Renal unit, Western Infirmary, Glasgow, providing both dialysis and renal transplantation. PATIENTS: 82 Diabetic patients starting renal replacement treatment between 1979 and 1988, compared with 82 matched non-diabetic controls with renal failure and 39 different matched controls undergoing renal transplantation. MAIN OUTCOME MEASURES: Patient characteristics, history of smoking, prevalence of left ventricular hypertrophy and myocardial ischaemia at start of renal replacement treatment; survival of patients with renal replacement treatment and of patients and allografts with renal transplantation. RESULTS: The overall survival of the diabetic patients during the treatment was 83%, 59%, and 50% at one, three, and five years. Survival was significantly poorer in the diabetic patients than the controls (p less than 0.001). Particularly adverse features for outcome at the start of treatment were increasing age (p less than 0.01) and current cigarette smoking (relative risk (95% confidence interval) 2.28 (0.93 to 4.84), p less than 0.05). Deaths were mainly from cardiac and vascular causes. The incidence of peritonitis in patients on continuous ambulatory peritoneal dialysis was the same in diabetic patients and controls (49% in each group remained free of peritonitis after one year), and the survival of renal allografts was not significantly worse in diabetic patients (p less than 0.5). CONCLUSIONS: Renal replacement treatment may give good results in diabetic patients, although the outlook remains less favourable than for non-diabetic patients because of coexistent, progressive vascular disease, which is more severe in older patients.
OBJECTIVE: To compare the outcome of renal replacement treatment in patients with diabetes mellitus and in non-diabeticpatients with end stage renal failure. DESIGN: Retrospective comparison of cases and matched controls. SETTING: Renal unit, Western Infirmary, Glasgow, providing both dialysis and renal transplantation. PATIENTS: 82 Diabeticpatients starting renal replacement treatment between 1979 and 1988, compared with 82 matched non-diabetic controls with renal failure and 39 different matched controls undergoing renal transplantation. MAIN OUTCOME MEASURES: Patient characteristics, history of smoking, prevalence of left ventricular hypertrophy and myocardial ischaemia at start of renal replacement treatment; survival of patients with renal replacement treatment and of patients and allografts with renal transplantation. RESULTS: The overall survival of the diabeticpatients during the treatment was 83%, 59%, and 50% at one, three, and five years. Survival was significantly poorer in the diabeticpatients than the controls (p less than 0.001). Particularly adverse features for outcome at the start of treatment were increasing age (p less than 0.01) and current cigarette smoking (relative risk (95% confidence interval) 2.28 (0.93 to 4.84), p less than 0.05). Deaths were mainly from cardiac and vascular causes. The incidence of peritonitis in patients on continuous ambulatory peritoneal dialysis was the same in diabeticpatients and controls (49% in each group remained free of peritonitis after one year), and the survival of renal allografts was not significantly worse in diabeticpatients (p less than 0.5). CONCLUSIONS: Renal replacement treatment may give good results in diabeticpatients, although the outlook remains less favourable than for non-diabeticpatients because of coexistent, progressive vascular disease, which is more severe in older patients.
Authors: F P Brunner; W Fassbinder; M Broyer; R Oulès; H Brynger; G Rizzoni; S Challah; N H Selwood; S R Dykes; A J Wing Journal: Nephrol Dial Transplant Date: 1988 Impact factor: 5.992
Authors: R Gokal; C Jakubowski; J King; L Hunt; S Bogle; R Baillod; F Marsh; C Ogg; D Oliver; M Ward Journal: Lancet Date: 1987-11-14 Impact factor: 79.321
Authors: H H Parving; E Hommel; E Mathiesen; P Skøtt; B Edsberg; M Bahnsen; M Lauritzen; P Hougaard; E Lauritzen Journal: Br Med J (Clin Res Ed) Date: 1988-01-16
Authors: Marielle A Schroijen; Olaf M Dekkers; Diana C Grootendorst; Marlies Noordzij; Johannes A Romijn; Raymond T Krediet; Elisabeth W Boeschoten; Friedo W Dekker Journal: BMC Nephrol Date: 2011-12-19 Impact factor: 2.388